Background: Two methods have been developed and validated for the determination of free and total dopamine in human plasma. They are based on solid-phase extraction of the analyte from the matrix by covalent complexation with phenylboronic acid, followed by derivatization with ethylchloroformate. The derivative is quantified by reversed-phase liquid chromatography on a C18 column and positive electrospray ionization MS/MS. Results: The high selectivity obtained, in combination with the stable and relatively non-polar nature of the derivatized analyte, enables the reliable quantification of dopamine in the range 0.05 to 20 ng/ml in a 5 min run time, using only 100 µl of sample. Total dopamine concentrations are determined (range 1 to 400 ng/ml) by including an acidic hydrolysis step, which converts the sulphate and glucuronide conjugates to free dopamine prior to extraction. The method was applied to quantify free and total dopamine levels in human plasma after dosing with the anti-Parkinson’s drug combination L-dopa/carbidopa with and without entacapone. Conclusion: A sensitive and selective LC–MS/MS method has been developed and validated for the determination of free and total dopamine in human plasma. This article demonstrates how essential careful optimization of the sample preparation procedures was for developing a successful method.

Papers of special note have been highlighted as: ▪ of interest

Bibliography

1 Rosano TG, Eisenhofer G, Whitley RJ. Catecholamines and serotonin. In: Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Burtis CA, Ashwood ER, Bruns DE (Eds). Elsevier Saunders, St Louis, MO, USA, 1033–1074 (2006).
Google Scholar
2 Eldrup E, Møller SE, Andreasen J, Christensen NJ. Effects of ordinary meals on plasma concentrations of 3,4-dihydroxyphenylalanine, dopamine sulphate and 3,4-dihydroxyphenylacetic acid. Clin. Sci.92,423–430 (1997).
Medline CASGoogle Scholar
3 Nord M, Zsigmond P, Kullman A, Arstrand K, Dizdar N. The effect of peripheral enzyme inhibitors on levodopa concentrations in blood and CSF. Mov. Disord.25,363–367 (2010).
MedlineGoogle Scholar
4 Rosano TG, Swift TA, Hayes LW. Advances in catecholamine and metabolite measurements for diagnosis of pheochromocytoma. Clin. Chem.37,1854–1867 (1991).
Medline CASGoogle Scholar
5 Abe M, Iwaoka M, Nakamura T et al. Association of high levels of plasma free dopamine with future coronary events in patients with coronary artery disease. Circ. J.71,688–692 (2007).
Medline CASGoogle Scholar
6 Boomsma F, Alberts G, van Eijk L, Man in’t Veld AJ, Schalekamp MADH. Optimal collection and storage conditions for catecholamine measurements in human plasma and urine. Clin. Chem.39,2503–2508 (1993).▪ Good overview of different stabilizing procedures for catecholamines in plasma and urine.
Medline CASGoogle Scholar
7 Tsunoda M. Recent advances in methods for the analysis of catecholamines and their metabolites. Anal. Bioanal. Chem.386,506–514 (2006).▪ Recent methods for catecholamines and metabolites in biological samples.
Medline CASGoogle Scholar
8 Bergquist J, Sciubisz A, Kaczor A, Silberring J. Catecholamines and methods for their identification and quantitation in biological tissues andfluids. J. Neurosci. Methods113,1–13 (2002).
Medline CASGoogle Scholar
9 Boomsma F, Alberts G, van der Hoorn FAJ, Man in’t Veld AJ, Schalekamp MADH. Simultaneous determination of free catecholamines and epinine and estimation of total epinine and dopamine in plasma and urine by high-performance liquid chromatography with fluorimetric detection. J. Chromatogr.574,109–117 (1992).
Medline CASGoogle Scholar
10 Sällström S, Rommelspacher H. Determination of total dopamine, R- and S-salsolinol in human plasma by cyclodextrin bonded-phase liquid chromatography with electrochemical detection. J. Chromatogr. B660,235–241 (1994).
MedlineGoogle Scholar
11 Eckstein JA, Ammerman GM, Reveles JM, Ackermann B, Simultaneous profiling of multiple neurochemical pathways from a single cerebrospinal fluid sample using GC/MS/MS with electron capture detection. J. Mass Spectrom.43,782–790 (2008)
Medline CASGoogle Scholar
12 Kushnir MM, Urry FM, Frank EL, Roberts WL, Shushan B. Analysis of catecholamines in urine by positive-ion electrospray tandem mass spectrometry. Clin. Chem.48,323–331 (2002).
Medline CASGoogle Scholar
13 Li W, Rossi DT, Fountain ST. Development and validation of a semi-automated method for L-dopa and dopamine in rat plasma using electrospray LC–MS/MS. J. Pharm. Biomed. Anal.24,325–333 (2000).
Medline CASGoogle Scholar
14 Ji C, Li W, Ren X et al. Diethylation labeling combined with UPLC–MS/MS for simultaneous determination of a panel of monoamine neurotransmitters in rat prefrontal cortex microdialysates. Anal. Chem.80,9195–9203 (2008).
Medline CASGoogle Scholar
15 Lee J, Huang BX, Yan Z, Kim HY. Simultaneous determination of salsolinol enantiomers and dopamine in human plasma and cerebrospinal fluid by chemical derivatization coupled to chiral liquid chromatography/electrospray ionization-tandem mass spectrometry. Anal. Chem.79,9166–9173 (2007).
Medline CASGoogle Scholar
16 Hashizume K, Yamatodani A, Ogihara T. Free and total dopamine in human plasma: effects of posture, age and some pathophysiological conditions. Hypertens. Res.18,S205-S207 (1995).
Medline CASGoogle Scholar
17 US Food and Drug Administration, Guidance for Industry, Bioanalytical Method Validation, May 2001.
Google Scholar
18 van de Merbel NC. Quantitative determination of endogenous compounds by chromatographic techniques. Trends Anal. Chem.27,924–933 (2008).
CASGoogle Scholar
19 Miki K, Sudo A. Effect of urine pH, storage time and temperature on stability of catecholamines, cortisol and creatinine. Clin. Chem.44,1759–1762 (1998).
Medline CASGoogle Scholar
20 Al-Shammary FJ. Sample preparation of catecholamines and biologically active peptides by solid-phase extraction. J. High Res. Chromatogr.13,309–311 (1990).
CASGoogle Scholar
21 Smedes F, Kraak JC, Poppe H. Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine. J. Chromatogr.231,25–39 (1982).
Medline CASGoogle Scholar
22 de Jong WHA, de Vries EGE, Wolffenbuttel BHR, Kema IP. Automated mass spectrometric analysis of urinary free catecholamines using on-line solid phase extraction. J. Chromatogr. B878,1506–1512 (2010).
Medline CASGoogle Scholar
23 Törnkvist A, Sjöberg PJR, Markides KE, Bergquist J. Analysis of catecholaminesand related substances using porous graphitic carbon as separation media in liquid chromatography–tandem mass spectrometry. J. Chromatogr. B801,323–329 (2004).
Medline CASGoogle Scholar
24 Khuhawar MY, Zardari LA, Laghari AJ. Ethyl chloroformate as a derivatizing reagent for capillary GC determination of dopamine, adrenaline, putrescine and histamine. Chromatographia67,847–851 (2008).
CASGoogle Scholar

Vol. 3, No. 17

Metrics

Downloaded 769 times

History

Published online 8 September 2011

Published in print September 2011

Information

Ethical conduct of research

The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigation involving human subjects, informed consent has been obtained from the participants involved.

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.

PDF download